dr. donington on the role of neoadjuvant immunotherapy in stage ii nsclc
Published 4 years ago • 172 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:28
dr. donington on neoadjuvant immunotherapy in lung cancer
-
0:59
dr. weksler on neoadjuvant and adjuvant therapy in nsclc
-
3:06
adjuvant versus neoadjuvant therapy in nsclc
-
6:45
neoadjuvant nivolumab in nsclc
-
4:41
immunotherapy for operable nsclc
-
1:24
dr. kelly on preliminary data with neoadjuvant immunotherapy in lung cancer
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
5:25
immunotherapy in lung cancer
-
1:33
dr. chaft on the rise of immunotherapy in lung cancer
-
1:32
dr. goldman on the use of immunotherapy in oncogene-driven nsclc
-
1:20
dr. johnson on the future of immunotherapy in lung cancer
-
2:34
the future of immunotherapy in nsclc
-
2:12
neoadjuvant pembrolizumab for lung cancer | nejm
-
56:12
from concept to indication: neoadjuvant immunotherapy for operable lung cancer
-
1:04
dr. lilenbaum on the promising future direction of immunotherapy in lung cancer
-
1:14
dr. brahmer on immunotherapy in stage iv nsclc
-
45:21
advances in immunotherapy & resectable non-small cell lung cancer
-
1:29
dr. bunn on the response of immunotherapy in lung cancer
-
1:40
dr jessica donington: osteopontin's role in lung cancer detection and prognosis